BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2024 3:11:19 PM | Browse: 94 | Download: 152
 |
Received |
|
2024-03-14 07:19 |
|
Peer-Review Started |
|
2024-03-14 07:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-29 16:26 |
|
Revised |
|
2024-05-21 06:59 |
|
Second Decision |
|
2024-06-21 02:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-06-21 06:37 |
|
Articles in Press |
|
2024-06-21 06:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-28 07:49 |
|
Publish the Manuscript Online |
|
2024-08-27 15:11 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
New therapy for metabolic syndrome: Gut microbiome supplementation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Waseem Qureshi, Maqsood Ahmad Dar and Mohd Younis Rather |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Waseem Qureshi, Doctor, FRCP, FRCPE, MBBS, MD, Chief Physician, Doctor, Doctor, Professor, Superintendent, Hospital Administration, Government Medical College, University of Kashmir, Gole Market-10, Srinagar 190010, Jammu and Kashmir, India. qureshiwaseem786@gmail.com |
| Key Words |
Probiotics; Prebiotics; Synbiotics; Postbiotics; Microbiome; Type 2 diabetes mellitus; Cardiovascular disease; Obesity |
| Core Tip |
The gut microbiota plays a crucial role in the onset and progression of metabolic conditions like type 2 diabetes, cardiovascular disease, and obesity. This diverse microbial community regulates various physiological functions, including metabolism, inflammation, and immune response. Understanding these interactions has led to innovative therapeutic approaches, such as microbiome supplementation. Dietary changes significantly impact the composition and function of the gut microbiome, influencing metabolite production that directly impacts host well-being. Certain metabolites like butyrate and propionate exhibit protective effects against metabolic disorders, while trimethylamine is associated with cardiovascular risk. Researchers explore prebiotics, probiotics, synbiotics, and postbiotics as potential avenues to modulate the gut microbiome and enhance metabolic health. Despite therapeutic advancements and lifestyle modifications, the prevalence of metabolic syndrome continues to rise, underscoring the urgent need for novel treatments. |
| Publish Date |
2024-08-27 15:11 |
| Citation |
<p>Qureshi W, Dar MA, Rather MY. New therapy for metabolic syndrome: Gut microbiome supplementation. <i>World J Diabetes</i> 2024; 15(9): 1833-1836</p> |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i9/1833.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i9.1833 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
